▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Abivax Société Anonyme (NASDAQ: ABVX)

$71.94

(0.2%)

$0.18

Price as of August 1, 2025, 4:00 p.m. ET

Abivax Société Anonyme Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
ABVX	+507.71%			+765%
S&P	+14.53%	+90.70%	+13.76%	+48%

Abivax Société Anonyme Company Info

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

News & Analysis

Featured Article

This Stock Is Up by 800% This Year -- but Is It a Buy?

This little-known biotech might still deliver strong returns.

Prosper Junior Bakiny | Jul 31, 2025

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services